We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIDP
RNS Number : 9885O
InnovaDerma PLC
11 November 2016
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.
InnovaDerma PLC ("InnovaDerma" or the "Company")
Announcement of Director / PDMR shareholding
The Company was notified on 7 November 2016, that Zaymar Investments Pty Ltd sold 12,500 Ordinary Shares of EUR0.10 each in the Company on 31 October 2016 at a price of GBP1.25 per share and 12,500 Ordinary Shares of EUR0.10 each in the Company on 1 November 2016 at a price of GBP1.00 per share (the "Sale"). Zaymar Investments Pty Ltd is owned and controlled by Haris Altaf Chaudhry, Executive Chairman of InnovaDerma plc.
Both transactions took place on the London Stock Exchange. As a result of these transactions, Haris Altaf Chaudhry's interest in the ordinary share capital of the Company, including that of his connected persons, reduced from 6,018,326 to 5,993,326. Following the Sale, Haris Altaf Chaudhry and his connected persons will retain beneficial interests in approximately 57.9% of the entire issued share capital of the Company.
This notice is given in fulfilment of obligations under DTR 3.1.2R.
Further enquiries:
InnovaDerma PLC Haris Chaudhry/Joe Bayer +61 (0)3 9111 0071 ----------------------------- ---------------------- Sole broker Hybridan LLP +44 (0)203 764 2341 Claire Noyce/Niall Pearson / 2343 ----------------------------- ---------------------- Cardew Group Shan Shan Willenbrock David Roach Emma Ruttle +44 (0)20 7930 0777 ----------------------------- ----------------------
About InnovaDerma:
InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.
www.innovaderma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUARARNKAAAAA
(END) Dow Jones Newswires
November 11, 2016 06:23 ET (11:23 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
